Interleukin 23 Levels Are Increased in Carotid Atherosclerosis
Author(s) -
Azhar Abbas,
Ida Gregersen,
Sverre Holm,
Isabelle Daissormont,
Vigdis Bjerkeli,
Kirsten KrohgSørensen,
Karolina Skagen,
Tuva B. Dahl,
David Russell,
Trine Almås,
D. Bundgaard,
Lars Alteheld,
Azita Rashidi,
Christen P. Dahl,
Annika E. Michelsen,
Erik A.L. Biessen,
Pål Aukrust,
Bente Halvorsen,
Mona Skjelland
Publication year - 2015
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.114.006516
Subject(s) - medicine , peripheral blood mononuclear cell , inflammation , pathology , immunostaining , cytokine , interleukin , population , tumor necrosis factor alpha , immunohistochemistry , in vitro , biology , biochemistry , environmental health
Interleukin (IL)-23 is a cytokine in the IL-12 family, mainly produced by antigen-presenting cells with a central role in inflammation. We hypothesize that IL-23 is also important in atherogenesis and investigate this in a population with carotid atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom